Fierce Pharma

SEPTEMBER 6, 2024

GSK is heading into the weekend with a win for its respiratory blockbuster Nucala—but for now, the details are slim. | On Friday, GSK said that its IL-5 antibody Nucala plus inhaled maintenance therapy lowered the annualized rate of moderate or severe exacerbations among chronic obstructive pulmonary disease (COPD) patients for up to 2 years. Nucala is already approved in a range of respiratory conditions, but a COPD nod could present another big opportunity for the drug.

FDA 303

FDA Patients 303

Pharmaceutical Technology

SEPTEMBER 6, 2024

The US FDA has granted orphan drug designation (ODD) to Abdera Therapeutics’ ABD-147 aimed at neuroendocrine carcinoma.

FDA 124

FDA 124

Fierce Pharma

SEPTEMBER 6, 2024

Gilead Sciences has been looking for a win for Trodelvy after two surprise trial failures earlier this year. | Gilead Sciences has been looking for a win for Trodelvy after two surprise trial failures earlier this year. But it looks like that win won’t come from a triplet regimen that combines the antibody-drug conjugate with Merck’s Keytruda and chemotherapy in newly diagnosed non-small cell lung cancer.

298

298

MedCity News

SEPTEMBER 6, 2024

By 2030, the U.S. expects shortages of 200,000 nurses and 124,000 physicians snd similar shortages are already being felt in the U.K. and elsewhere. Here’s how to build and train a modern healthcare workforce in the age of AI The post Can AI Help Fix Our Demographic Time Bomb? appeared first on MedCity News.

Physicians 122

Physicians Training Healthcare Healthcare 122

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

SEPTEMBER 6, 2024

Astellas is closing a gene therapy manufacturing facility in South San Francisco. But, across the country, the company opened a new R&D center in Massachusetts. | Astellas is closing a gene therapy manufacturing facility in South San Francisco. But across the country, the company opened a new R&D center in Massachusetts. Chinese authorities detained several current or former AstraZeneca employees.

Manufacturing 130

Manufacturing Pharma 130

MedCity News

SEPTEMBER 6, 2024

The FDA decision for Travere Therapeutics’ Filspari also expands its addressable patient population. The full approval comes nearly a year after the Travere drug narrowly missed the main goal of its confirmatory study. The post Full FDA Approval of Travere’s Kidney Drug Stiffens Competition With Novartis, Calliditas appeared first on MedCity News.

Competition 121

Competition FDA Patients Biopharma 121

MedCity News

SEPTEMBER 6, 2024

Local health department staffing grew by about 19% from 2019 to 2022, according to a report from the National Association of County and City Health Officials that studied 2,512 of the nation’s roughly 3,300 local departments. But those jobs, and the safety net they provide for the people in the communities served, are vulnerable as the money dries up, The post Boom, Now Bust: Budget Cuts and Layoffs Take Hold in Public Health appeared first on MedCity News.

Safety 119

Safety 119

pharmaphorum

SEPTEMBER 6, 2024

GSK's severe asthma therapy Nucala could find a new lease of life as a treatment for chronic obstructive pulmonary disease (COPD) after showing a clear benefit in a phase 3 trial.

111

111

MedCity News

SEPTEMBER 6, 2024

Check out news from Oral Genome, Carrot Fertility, Thatch, and The Perryman Group. The post StartUPDATES: New Developments for Healthcare Startups appeared first on MedCity News.

Healthcare 115

Healthcare Healthcare Biopharma 115

pharmaphorum

SEPTEMBER 6, 2024

The fallout from the FDA's recent decision not to approve Lykos Therapeutics' psychedelic treatment has spread to its senior management, with chief executive Amy Emerson stepping down.

FDA 108

FDA Management 108

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

SEPTEMBER 6, 2024

By actively and consistently collecting feedback, hospitals can gain rapid insights into critical areas, allowing them to track and measure patient satisfaction levels, and crucially to react to any dips in standards of care. The post How Data Feedback Can Aid Patient Experience in Healthcare appeared first on MedCity News.

Healthcare 110

Healthcare Healthcare Patients 110

PharmaTimes

SEPTEMBER 6, 2024

New treatment could simplify diabetes management for millions

Management 106

Management 106

pharmaphorum

SEPTEMBER 6, 2024

Eli Lilly signs another genetic medicines deal, this time with Genetic Leap, a start-up that applies AI to the discovery of RNA-targeted drugs.

Medicine 104

Medicine 104

Pharmaceutical Technology

SEPTEMBER 6, 2024

The US FDA has approved Amneal Pharmaceuticals and Shilpa Medicare’s oncology product BORUZU for subcutaneous administration.

FDA 98

FDA Pharmaceutical 98

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

Dinamic OR

SEPTEMBER 6, 2024

Enhancing Cross-Functional Collaboration with DinamicOR’s Surgical Back Table and Workflow Management App In today’s healthcare environment, cross-functional teams are becoming increasingly essential, especially in operating rooms (ORs) where staff shortages are a growing concern. The shift toward interdisciplinary collaboration isn’t just a trend—it’s a necessity.

Management 95

Management Safety Healthcare Healthcare 95

MedCity News

SEPTEMBER 6, 2024

Mayo Clinic recently launched a collaboration with Exer AI, a Denver-based startup. The AI company seeks to improve diagnosis and treatment for musculoskeletal and motion disorders wherever the patient is — whether that be in their provider’s office, their home or via telehealth appointment. The post Mayo Clinic Taps AI Startup to Improve MSK Care appeared first on MedCity News.

Patients 72

Patients Healthcare Healthcare 72

Healthcare Success

SEPTEMBER 6, 2024

On August 14, 2024, the Federal Trade Commission (FTC) introduced a rule banning fake reviews and misleading testimonials to improve marketing transparency and authenticity. As a healthcare organization, you already prioritize ethical practices and HIPAA compliance due to the nature of your business. It’s important to adapt to these new changes to maintain patient trust and remain competitive.

Ethics 62

Ethics Media Training Healthcare 62

PharmaVoice

SEPTEMBER 6, 2024

The factors driving the industry’s layoffs — and what could help turn the tide.

59

59

Advertisement

Pharmacy Times

SEPTEMBER 6, 2024

Full traditional approval follows accelerated approval of the medication last year.

Medical 57

Medical FDA 57

Pharmaceutical Commerce

SEPTEMBER 6, 2024

The enhancement—which complements the CDMO’s adeno-associated viral vector services—will be utilized at the company’s advanced therapies site in Stevenage, UK.

Biopharma 52

Biopharma Manufacturing 52

Pharmacy Times

SEPTEMBER 6, 2024

Individuals with a history of shingles was significantly and independently connected with a 20% higher risk of for subjective cognitive decline.

55

55

PharmExec

SEPTEMBER 6, 2024

Texas Biomed announced that research shows that a certain monoclonal antibody treatment could treat all variants of COVID-19, including past, present, and future strains.

52

52

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

Pharmacy Times

SEPTEMBER 6, 2024

The evolving treatment landscape for multiple myeloma includes debates on the timing and effectiveness of CAR T-cell therapy and quadruple immunotherapy regimens.

52

52

European Pharmaceutical Review

SEPTEMBER 6, 2024

Results from a Phase I/II gene therapy trial have demonstrated that ATSN-101 enabled patients with a rare inherited disease to gain substantial, rapid improvement in their vision. Participants with Leber congenital amaurosis (LCA1) due to mutations in the GUCY2D gene were evaluated in the one-year clinical trial. Of the 15 participants, three were paediatric subjects.

Patients 52

Patients Leads Pharmaceutical 52

Pharmacy Times

SEPTEMBER 6, 2024

New transparency initiatives will go into effect on January 1, 2025, building off previous actions by the Centers of Medicare and Medicaid Services.

52

52

PharmExec

SEPTEMBER 6, 2024

Results from the MATINEE trial found that Nucala led to a statistically significant and clinically meaningful reduction in moderate/severe exacerbations of chronic obstructive pulmonary disease compared to placebo over 104 weeks.

52

52

Advertisement

Distribution

Pharmaceutical Technology

SEPTEMBER 6, 2024

The atopic dermatitis market is facing increased growth, with a projected market value of $16.7bn by 2030 for the 7MM, according to GlobalData.

Marketing 52

Marketing 52

PharmExec

SEPTEMBER 6, 2024

Boruzu is the first ready-to-use version of bortezomib for subcutaneous and intravenous administration in the treatment of multiple myeloma and mantle cell lymphoma.

FDA 52

FDA 52

Pharmaceutical Technology

SEPTEMBER 6, 2024

The company had focused its resources on Filspari’s launch in IgAN after the US FDA snubbed the therapy in another rare kidney disorder.

FDA 52

FDA 52

PharmaTech

SEPTEMBER 6, 2024

Viral vectors and other complex biologic modalities require more specificity and higher sensitivity to detect and distinguish contaminants.

52

52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales